Log In
Print this Print this

Endometrial Regenerative Cells (ERCs) (ERC-124)

  Manage Alerts
Collapse Summary General Information
Company Intrexon Corp.
DescriptionUniversal donor stem cells derived from menstrual blood
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today